Literature DB >> 28183804

Reduced mitochondrial activity in colonocytes facilitates AMPKα2-dependent inflammation.

Sandra Heller1, Harrison M Penrose1, Chloe Cable1, Debjani Biswas1, Hani Nakhoul1, Melody Baddoo1, Erik Flemington1, Susan E Crawford2, Suzana D Savkovic3.   

Abstract

Intestinal inflammation is associated with low levels of mucosal ATP, highlighting the importance of mitochondrial function associated with ATP production in the pathophysiology of the disease. In the inflamed colon of humans and mice, we found decreased levels of mitochondrial complex cytochrome c oxidase I/IV and lower ATP levels. Thus, we generated colonic ρ0 cells with reduced mitochondrial function linked to ATP production by selective depletion of mitochondrial DNA. In these cells, RNA sequencing revealed a substantial number of differentially expressed transcripts, among which 240 belonged to inflammatory pathways activated in human inflamed colon and TNF-α-treated cells (false discovery rate < 0.05). TNF-α treatment of colonic ρ0 cells augmented IL-8 expression by 9-fold (P < 0.01) via NF-κB compared to TNF-α-treated control. Moreover, reduced mitochondrial function facilitated TNF-α-mediated NF-κB luciferase promoter activity as a result of lowered inhibitory IκBα (nuclear factor of κ light polypeptide gene enhancer in B-cell inhibitor, α), leading to elevated NF-κB. In cells with reduced mitochondrial function, TNF-α facilitated AMPKα2 activation by 8-fold (P < 0.01), which was involved in NF-κB-dependent IL-8 expression. Last, in human and mouse colon, anti-TNF-α treatment restored reduced mitochondria-dependent inflammation. We propose that selective targeting of this novel mechanism provides new treatment opportunities for intestinal inflammation.-Heller, S., Penrose, H. M., Cable, C., Biswas, D., Nakhoul, H., Baddoo, M., Flemington, E., Crawford, S. E., Savkovic, S. D. Reduced mitochondrial activity in colonocytes facilitates AMPKα2-dependent inflammation. © FASEB.

Entities:  

Keywords:  RNA-seq; inflammatory bowel disease; intestine; ρ0 cells

Mesh:

Substances:

Year:  2017        PMID: 28183804      PMCID: PMC5388551          DOI: 10.1096/fj.201600976R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  60 in total

Review 1.  Supramolecular structure of the mitochondrial oxidative phosphorylation system.

Authors:  Egbert J Boekema; Hans-Peter Braun
Journal:  J Biol Chem       Date:  2006-11-13       Impact factor: 5.157

Review 2.  Structural basis of signal transduction in the TNF receptor superfamily.

Authors:  Jixi Li; Qian Yin; Hao Wu
Journal:  Adv Immunol       Date:  2013       Impact factor: 3.543

Review 3.  Healing the epithelium: solving the problem from two sides.

Authors:  D K Podolsky
Journal:  J Gastroenterol       Date:  1997-02       Impact factor: 7.527

4.  EBSeq: an empirical Bayes hierarchical model for inference in RNA-seq experiments.

Authors:  Ning Leng; John A Dawson; James A Thomson; Victor Ruotti; Anna I Rissman; Bart M G Smits; Jill D Haag; Michael N Gould; Ron M Stewart; Christina Kendziorski
Journal:  Bioinformatics       Date:  2013-02-21       Impact factor: 6.937

5.  DNA biosynthesis in mitochondria. Differential inhibition of mitochondrial and nuclear DNA polymerases by the mutagenic dyes ethidium bromide and acriflavin.

Authors:  R R Meyer; M V Simpson
Journal:  Biochem Biophys Res Commun       Date:  1969-01-27       Impact factor: 3.575

6.  Peroxisome Proliferator-activated Receptor-γ Coactivator 1-α (PGC1α) Protects against Experimental Murine Colitis.

Authors:  Kellie E Cunningham; Garret Vincent; Chhinder P Sodhi; Elizabeth A Novak; Sarangarajan Ranganathan; Charlotte E Egan; Donna Beer Stolz; Matthew B Rogers; Brian Firek; Michael J Morowitz; George K Gittes; Brian S Zuckerbraun; David J Hackam; Kevin P Mollen
Journal:  J Biol Chem       Date:  2016-03-11       Impact factor: 5.157

7.  Altered ascorbic acid status in the mucosa from inflammatory bowel disease patients.

Authors:  G D Buffinton; W F Doe
Journal:  Free Radic Res       Date:  1995-02

Review 8.  Regulation of human interleukin 8 gene expression and binding of several other members of the intercrine family to receptors for interleukin-8.

Authors:  N Mukaida; A Hishinuma; C O Zachariae; J J Oppenheim; K Matsushima
Journal:  Adv Exp Med Biol       Date:  1991       Impact factor: 2.622

9.  Mitochondrial dysfunction, persistent oxidative damage, and catalase inhibition in immune cells of naïve and treated Crohn's disease.

Authors:  Belén Beltrán; Pilar Nos; Francisco Dasí; Marisa Iborra; Guillermo Bastida; Marcial Martínez; José-Enrique O'Connor; Guillermo Sáez; Inés Moret; Julio Ponce
Journal:  Inflamm Bowel Dis       Date:  2010-01       Impact factor: 5.325

10.  RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome.

Authors:  Bo Li; Colin N Dewey
Journal:  BMC Bioinformatics       Date:  2011-08-04       Impact factor: 3.307

View more
  10 in total

1.  Gut microbes effects on host metabolic alterations in health and disease.

Authors:  Suzana D Savkovic
Journal:  Gut Microbes       Date:  2020-05-03

2.  OMA1 reprograms metabolism under hypoxia to promote colorectal cancer development.

Authors:  Zhida Wu; Meiling Zuo; Ling Zeng; Kaisa Cui; Bing Liu; Chaojun Yan; Li Chen; Jun Dong; Fugen Shangguan; Wanglai Hu; He He; Bin Lu; Zhiyin Song
Journal:  EMBO Rep       Date:  2020-12-13       Impact factor: 9.071

3.  Loss of Forkhead Box O3 Facilitates Inflammatory Colon Cancer: Transcriptome Profiling of the Immune Landscape and Novel Targets.

Authors:  Harrison M Penrose; Chloe Cable; Sandra Heller; Nathan Ungerleider; Hani Nakhoul; Melody Baddoo; Alifiani B Hartono; Sean B Lee; Matthew E Burow; Erik F Flemington; Susan E Crawford; Suzana D Savkovic
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2018-10-13

Review 4.  Gut bacteria signaling to mitochondria in intestinal inflammation and cancer.

Authors:  Dakota N Jackson; Arianne L Theiss
Journal:  Gut Microbes       Date:  2019-03-26

5.  Ulcerative colitis immune cell landscapes and differentially expressed gene signatures determine novel regulators and predict clinical response to biologic therapy.

Authors:  Harrison M Penrose; Rida Iftikhar; Morgan E Collins; Eman Toraih; Emmanuelle Ruiz; Nathan Ungerleider; Hani Nakhoul; Erik F Flemington; Emad Kandil; Shamita B Shah; Suzana D Savkovic
Journal:  Sci Rep       Date:  2021-04-27       Impact factor: 4.379

Review 6.  The Role of Mitochondria Dysfunction in Inflammatory Bowel Diseases and Colorectal Cancer.

Authors:  Patrycja Kłos; Siarhei A Dabravolski
Journal:  Int J Mol Sci       Date:  2021-10-28       Impact factor: 5.923

7.  Immune Cells and Transcriptional Signatures Revealed Novel Regulators and Predict Clinical Response to Biologic Therapy in Ulcerative Colitis.

Authors:  Suzana D Savkovic
Journal:  J Cell Immunol       Date:  2021

8.  The role of the mitochondrial protein VDAC1 in inflammatory bowel disease: a potential therapeutic target.

Authors:  Ankit Verma; Srinivas Pittala; Belal Alhozeel; Anna Shteinfer-Kuzmine; Ehud Ohana; Rajeev Gupta; Jay H Chung; Varda Shoshan-Barmatz
Journal:  Mol Ther       Date:  2021-07-02       Impact factor: 11.454

9.  In colonic ρ0 (rho0) cells reduced mitochondrial function mediates transcriptomic alterations associated with cancer.

Authors:  Harrison M Penrose; Sandra Heller; Chloe Cable; Hani Nakhoul; Nate Ungerleider; Melody Baddoo; Zachary F Pursell; Erik K Flemington; Susan E Crawford; Suzana D Savkovic
Journal:  Oncoscience       Date:  2017-12-27

10.  Olaparib: A Clinically Applied PARP Inhibitor Protects from Experimental Crohn's Disease and Maintains Barrier Integrity by Improving Bioenergetics through Rescuing Glycolysis in Colonic Epithelial Cells.

Authors:  Dominika Kovács; Viola Bagóné Vántus; Eszter Vámos; Nikoletta Kálmán; Rudolf Schicho; Ferenc Gallyas; Balázs Radnai
Journal:  Oxid Med Cell Longev       Date:  2021-09-14       Impact factor: 6.543

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.